Laboratory Corporation of America Holdings (LH) Shares Bought by Cetera Advisors LLC, Report finds

Laboratory Corporation of America Holdings (LH) Shares Bought by Cetera Advisors LLC, Report finds

Cetera Advisors LLC increased its stake in shares of Laboratory Corporation of America Holdings (NYSE:LH) by 9.7% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 3,228 shares of the company’s stock after buying an additional 286 shares during the period. Cetera Advisors LLC’s holdings in Laboratory Corporation of America Holdings were worth $448,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Xact Kapitalforvaltning AB purchased a new position in shares of Laboratory Corporation of America Holdings during the third quarter worth about $1,632,000. Horizon Investment Services LLC boosted its position in shares of Laboratory Corporation of America Holdings by 15.7% in the third quarter. Horizon Investment Services LLC now owns 27,895 shares of the company’s stock worth $3,835,000 after buying an additional 3,789 shares during the period. Mastrapasqua Asset Management Inc. boosted its position in shares of Laboratory Corporation of America Holdings by 111.3% in the third quarter. Mastrapasqua Asset Management Inc. now owns 35,421 shares of the company’s stock worth $4,870,000 after buying an additional 18,660 shares during the period. D. E. Shaw & Co. Inc. boosted its position in shares of Laboratory Corporation of America Holdings by 85.6% in the third quarter. D. E. Shaw & Co. Inc. now owns 148,337 shares of the company’s stock worth $20,394,000 after buying an additional 68,404 shares during the period. Finally, Ontario Teachers Pension Plan Board boosted its position in shares of Laboratory Corporation of America Holdings by 15.4% in the third quarter. Ontario Teachers Pension Plan Board now owns 44,994 shares of the company’s stock worth $6,186,000 after buying an additional 6,013 shares during the period. 92.19% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Laboratory Corporation of America Holdings (NYSE:LH) traded up 0.68% during mid-day trading on Wednesday, hitting $131.49. 645,893 shares of the company were exchanged. The company has a 50 day moving average of $131.86 and a 200 day moving average of $132.97. The company has a market capitalization of $13.54 billion, a P/E ratio of 20.85 and a beta of 0.94. Laboratory Corporation of America Holdings has a 52 week low of $100.98 and a 52 week high of $141.32.

A number of analysts have weighed in on LH shares. Zacks Investment Research lowered shares of Laboratory Corporation of America Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, October 25th. Gabelli started coverage on shares of Laboratory Corporation of America Holdings in a research report on Tuesday, October 25th. They issued a “buy” rating and a $180.00 target price on the stock. Robert W. Baird lowered shares of Laboratory Corporation of America Holdings from an “outperform” rating to a “neutral” rating and set a $138.00 target price on the stock. in a research report on Monday. Canaccord Genuity set a $140.00 target price on shares of Laboratory Corporation of America Holdings and gave the company a “buy” rating in a research report on Tuesday, January 17th. Finally, Deutsche Bank AG restated a “buy” rating and issued a $170.00 target price on shares of Laboratory Corporation of America Holdings in a research report on Wednesday, January 18th. Six investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Laboratory Corporation of America Holdings has an average rating of “Buy” and a consensus target price of $146.60.

Laboratory Corporation of America Holdings Company Profile

Laboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corporation of America Holdings (NYSE:LH).

Related posts

Leave a Comment

Laboratory Corporation of America Holdings (LH) Shares Bought by Cetera Advisors LLC

Laboratory Corporation of America Holdings (LH) Shares Bought by Cetera Advisors LLC

Cetera Advisors LLC increased its stake in shares of Laboratory Corporation of America Holdings (NYSE:LH) by 9.7% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 3,228 shares of the company’s stock after buying an additional 286 shares during the period. Cetera Advisors LLC’s holdings in Laboratory Corporation of America Holdings were worth $448,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Xact Kapitalforvaltning AB purchased a new position in shares of Laboratory Corporation of America Holdings during the third quarter worth about $1,632,000. Horizon Investment Services LLC boosted its position in shares of Laboratory Corporation of America Holdings by 15.7% in the third quarter. Horizon Investment Services LLC now owns 27,895 shares of the company’s stock worth $3,835,000 after buying an additional 3,789 shares during the period. Mastrapasqua Asset Management Inc. boosted its position in shares of Laboratory Corporation of America Holdings by 111.3% in the third quarter. Mastrapasqua Asset Management Inc. now owns 35,421 shares of the company’s stock worth $4,870,000 after buying an additional 18,660 shares during the period. D. E. Shaw & Co. Inc. boosted its position in shares of Laboratory Corporation of America Holdings by 85.6% in the third quarter. D. E. Shaw & Co. Inc. now owns 148,337 shares of the company’s stock worth $20,394,000 after buying an additional 68,404 shares during the period. Finally, Ontario Teachers Pension Plan Board boosted its position in shares of Laboratory Corporation of America Holdings by 15.4% in the third quarter. Ontario Teachers Pension Plan Board now owns 44,994 shares of the company’s stock worth $6,186,000 after buying an additional 6,013 shares during the period. 92.19% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Laboratory Corporation of America Holdings (NYSE:LH) traded up 0.68% during mid-day trading on Wednesday, hitting $131.49. 645,893 shares of the company were exchanged. The company has a 50 day moving average of $131.86 and a 200 day moving average of $132.97. The company has a market capitalization of $13.54 billion, a P/E ratio of 20.85 and a beta of 0.94. Laboratory Corporation of America Holdings has a 52 week low of $100.98 and a 52 week high of $141.32.

A number of analysts have weighed in on LH shares. Zacks Investment Research lowered shares of Laboratory Corporation of America Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, October 25th. Gabelli started coverage on shares of Laboratory Corporation of America Holdings in a research report on Tuesday, October 25th. They issued a “buy” rating and a $180.00 target price on the stock. Robert W. Baird lowered shares of Laboratory Corporation of America Holdings from an “outperform” rating to a “neutral” rating and set a $138.00 target price on the stock. in a research report on Monday. Canaccord Genuity set a $140.00 target price on shares of Laboratory Corporation of America Holdings and gave the company a “buy” rating in a research report on Tuesday, January 17th. Finally, Deutsche Bank AG restated a “buy” rating and issued a $170.00 target price on shares of Laboratory Corporation of America Holdings in a research report on Wednesday, January 18th. Six investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Laboratory Corporation of America Holdings has an average rating of “Buy” and a consensus target price of $146.60.

Laboratory Corporation of America Holdings Company Profile

Laboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corporation of America Holdings (NYSE:LH).

Related posts

Leave a Comment